Effects of xylazine on renal function and plasma glucose in ponies.
The intravenous administration of xylazine (1.1 mg/kg bodyweight) in six ponies resulted in a significant increase in urine output over two hours, with maximum flow occurring between 30 and 60 minutes after injection. Urine specific gravity, osmolality and glucose concentration decreased. Renal clearance of endogenous creatinine was unchanged. Significant increases in the excretion of potassium and chloride occurred. Plasma glucose concentration was increased 30 minutes after the administration of xylazine by a mean value of 37 per cent. Serum osmolality and sodium, potassium and chloride concentrations remained unchanged.
D000818:Animals; D001143:Arousal / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism*; D004573:Electrolytes / Q000652:urine; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006736:Horses; D007668:Kidney / Q000187:drug effects*; D007671:Kidney Concentrating Ability / Q000187:drug effects; D007677:Kidney Function Tests; D008297:Male; D013843:Thiazines / Q000494:pharmacology*; D014563:Urodynamics / Q000187:drug effects; D014991:Xylazine / Q000494:pharmacology*
D001786:Blood Glucose; D004573:Electrolytes; D013843:Thiazines; D014991:Xylazine